Scion Biomedical sues board member and interim chief strategy and operating officer Allison London Brown, accusing her and the medical device startup she founded, Aegis Women's Health Technology, of poaching trade secrets for its chitosan-based hemostasis products.
Scion Biomedical sued board member and interim chief strategy and operating officer Allison London Brown, accusing her of poaching trade secrets for her startup medical device company, Aegis Women's Health Technologies.
The lawsuit, filed in the U.S. District Court for Southern Florida, alleges that Brown pledge to keep her interests in Scion and Aegis separate but failed to do so. The lawsuit also accuses her of interfering with Scion's relationship with 1 of its scientific advisors and of filing a patent application that might include technology based on Scion's high molecular weight chitosan biomaterial, according to court documents.
"Brown abused her position and breached her fiduciary duty by, among other things, deliberately, without justification and dishonestly, usurping for Aegis a Scion business relationship, potentially misappropriating confidential information belonging to Scion, and upon information and belief, filing a patent application on behalf of her own company Aegis that may include chitosan-based technology," according to the documents. "Brown knew all along that she had no intention of merging Aegis into Scion on reasonable terms thereby sabotaging the capital raise, which is exactly what happened."